Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Bearish
4
Neutral
1
Bullish
9
Bearish
36
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stock
Medi Assist is a health benefits administrator and technology-led healthcare services company that connects insurers, employers, hospitals and members through claims processing, fraud detection, provider-network management and AI-powered digital platforms such as MAtrix, MAven Guard, Raksha Prime and MAgnum, operating across group, retail, government and international segments.
Q3 & 9M FY26 showed robust momentum: consolidated revenues grew ~29.9% in Q3 and ~24.0% for 9M, EBITDA margins expanded sequentially (154 bps QoQ consolidated improvement in Q3), and the company achieved a debt-free balance sheet in January 2026 with a free cash position of ₹200.1 Crore, strengthening financial flexibility.
Technology-led initiatives are scaling: technology revenues rose 81.5% YoY, MAven Guard identified ~₹400 Crore of FWA savings with 81.5% attributed to system/AI detection, Raksha Prime enables ~35,000 bill-free discharges per month across ~6,000 hospitals, and MAtrix platform migrations are underway with multiple insurers and international HealthX deployments.
Scale and market leadership are evident: Premiums under management reached ~₹19,289 Crore (+21.9% YoY), combined Group + Retail market share expanded to 21.1% with Group share at 32.2%, annual lives served exceed 39 Crore, and claims throughput is high at 72.9 Lakh claims for 9M, giving Medi Assist a structural operating advantage.
Integration and provisioning commentary matter: Paramount integration is progressing with QoQ margin improvement and a slump transfer approved, but exceptional items including a Paramount cyber incident and a prudent ₹7.1 Crore provision impacted 9M consolidated PAT; management’s steady-state PAT bridge indicates an estimated normalized PAT significantly higher than reported.
Healthcare
Medical Accessories / Disposables
2,416 Cr
Moderate Risk
40.3
27.4
1.1
3.1
594.40
297.75
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
323.80 | 2,416 Cr | 43.49 | 3.11 | 0.00 | 14.05 | 13.35 | 3.97 | |
1272.00 | 1,075 Cr | 18.74 | 3.60 | 0.32 | 16.47 | 21.74 | 17.06 | |
425.00 | 510 Cr | 25.76 | 4.42 | 0.24 | 16.98 | 22.79 | 15.94 | |
36.60 | 67 Cr | 11.40 | 0.63 | 1.37 | 3.22 | 5.30 | -1.67 | |
31.10 | 56 Cr | 135.11 | 2.26 | 0.21 | 1.57 | 4.13 | 1.44 | |
126.50 | 42 Cr | 95.11 | 5.16 | 0.04 | 7.12 | 10.19 | 4.85 | |
86.50 | 32 Cr | -29.03 | 1.09 | 0.00 | -6.78 | 1.96 | -1.30 |
Medi Assist Healthcare Services Ltd (MEDIASSIST) is currently trading at 300.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Medi Assist is a health benefits administrator and technology-led healthcare services company that connects insurers, employers, hospitals and members through claims processing, fraud detection, provider-network management and AI-powered digital platforms such as MAtrix, MAven Guard, Raksha Prime and MAgnum, operating across group, retail, government and international segments. Q3 & 9M FY26 showed robust momentum: consolidated revenues grew ~29.9% in Q3 and ~24.0% for 9M, EBITDA margins expanded sequentially (154 bps QoQ consolidated improvement in Q3), and the company achieved a debt-free balance sheet in January 2026 with a free cash position of ₹200.1 Crore, strengthening financial flexibility. Technology-led initiatives are scaling: technology revenues rose 81.5% YoY, MAven Guard identified ~₹400 Crore of FWA savings with 81.5% attributed to system/AI detection, Raksha Prime enables ~35,000 bill-free discharges per month across ~6,000 hospitals, and MAtrix platform migrations are underway with multiple insurers and international HealthX deployments. Scale and market leadership are evident: Premiums under management reached ~₹19,289 Crore (+21.9% YoY), combined Group + Retail market share expanded to 21.1% with Group share at 32.2%, annual lives served exceed 39 Crore, and claims throughput is high at 72.9 Lakh claims for 9M, giving Medi Assist a structural operating advantage. Integration and provisioning commentary matter: Paramount integration is progressing with QoQ margin improvement and a slump transfer approved, but exceptional items including a Paramount cyber incident and a prudent ₹7.1 Crore provision impacted 9M consolidated PAT; management’s steady-state PAT bridge indicates an estimated normalized PAT significantly higher than reported.
Over the past 52 weeks, Medi Assist Healthcare Services Ltd has traded between a low of ₹297.75 and a high of ₹594.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Medi Assist Healthcare Services Ltd has a market capitalization of approximately 2,415.85. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Medi Assist Healthcare Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 40.29 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,415.85 Cr, Medi Assist Healthcare Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Medi Assist Healthcare Services Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Medi Assist Healthcare Services Ltd is 40.29. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Net profit collapsed mainly due to a significant surge in operating expenses. Employee costs rose 30.85% and interest expenses increased by 236.95% year-on-year, which outpaced revenue growth and severely compressed profit margins.
